Geometry-based scaling standardized central target definition for SCART planning
A phantom-derived model predicted SCART central target radius with R² values of 0.991–0.999, but clinical validation remains absent.
A phantom-derived model predicted SCART central target radius with R² values of 0.991–0.999, but clinical validation remains absent.
A scanned helium beamline achieved submillimetre range accuracy and generally ≤3% dose agreement, supporting further translation toward clinical helium therapy.
Proton plans preserved 20-Gy target coverage while reducing spinal cord, oesophageal, lung, and bowel dose compared with photon VMAT.
Temporal lobe volumes receiving high dose or moderate dose with high LET jointly predicted grade 2 or higher necrosis.
Airbag compression reduced upper-abdominal respiratory motion comparably to a rigid plate but produced larger left–right setup errors.
ECHO generated consistent lung IMRT and VMAT plans while reducing active planner time by approximately 90 minutes per case.
AI-generated constraints produced clinically acceptable adaptive prostate plans, although only seven of ten met every prespecified planning objective.
PocketNet matched nnU-Net accuracy for cervical MRI segmentation while using 40-fold less storage and approximately half the training time.
Tumour-size strata showed non-monotonic BED–control relationships, while machine-learning performance remained unvalidated outside a single retrospective centre.
Strict exit-dose gamma thresholds correlated with anatomical change and identified all clinically replanned patients in a retrospective validation cohort.
Patient-specific reinforcement learning improved moving-target coverage over static GTV plans while reducing some normal-tissue exposure compared with ITV planning.
Automatically predicted coronary habitats captured most arteries and enabled substantial dose reductions in three retrospectively replanned thoracic cases.
gPRIDE closely matched Monte Carlo calculations for most anatomies and completed MRI-guided proton dose calculations within 13.7 seconds.
Adding the first treatment CBCT improved response and survival prediction, while additional scans progressively reduced classification performance.
Single-camera surface guidance provided comparable mean setup accuracy with less variability, while intrafraction breast motion remained below 3 mm in most observations.